Form EFFECT Mineralys Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 11, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- Apptunix Reinforces Its Position as a Leading Mobile App Development Company in Saudi Arabia and Middle East
- Momcozy Launches Its 99% Water Baby Wipes as the “1-Wipe Wonder” for Summer Parenting Chaos
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share